OKINEO System
ActiveSummary
The computed 12-month bankruptcy probability of OKINEO System is 1.7% (moderate). The 2025 annual accounts show equity of €39k and a net result of €18k. Equity is growing by ~37% per year across the filed fiscal years. Its solvency ranks better than 72% of 18280 sector peers (fiscal year 2025). The company has been active since 2021 and the Belgian State Gazette contains no insolvency or warning signals.
Checked score
Score 2025
75
/ 100
Excellent
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability100▲+27
Solvency86▲+14
Growth78▲+26
Track record94
Bankruptcy probability, 12 months
1.7%
Moderate
0%0.5%1.5%4%10%≥ 25%
Credit up to €2.5k at 30 days acceptable
Liquidity ample (current ratio 5.2 against 3.07 in 2024; short-term debt: 19.2% and cash: 18.1% of total assets), and 39.2% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation dateAge against the risk zone
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 47
Relative position
BE, all sectors
reference
Sector 47
higher
← fewer bankruptcies
more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
60.8%
Return on assets
27.4%
Age of the figures
9 mo
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 30-08-2026, 30 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 5 filingsDeviation from the deadline
2025
30 d late
2024
70 d late
2023
21 d early
2022
62 d early
2021
74 d early
← before the deadline
after the deadline →
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
24-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, micro schema
Equity
€39k▲ 82.3%
2024 · €21k
2021: €9k
2022: €12k
2023: €15k
2024: €21k
2021 → 2025
Total assets
€64k▲ 40.9%
2024 · €46k
2021: €53k
2022: €48k
2023: €46k
2024: €46k
2021 → 2025
Net result
€18k▲ 170%
2024 · €7k
2021: €8k
2022: €3k
2023: €3k
2024: €7k
2021 → 2025
Working capital
€52k▲ 68.7%
2024 · €31k
2021: €24k
2022: €23k
2023: €21k
2024: €31k
2021 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€9k-€12k▲ 31.4%€15k▲ 20.3%€21k▲ 43.8%€39k▲ 82.3%
Operating result€11k-€5k▼ 56.9%€4k▼ 7.0%€10k▲ 116%€25k▲ 168%
Net result€8k-€3k▼ 64.8%€3k▼ 15.1%€7k▲ 160%€18k▲ 170%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
After the dip in 2023 the operating result has climbed two years in a row; 2025 is 168% above 2024 and is the highest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Equity and liabilities €64k
Equity
€39k ▲ 82.3%
Debt
€25k ▲ 4.1%
Debt's share of the balance-sheet total falls from 53.0% to 39.2%. Equity and debt are higher.
Key figures and ratios
Current ratio
5.20▲
2024 · 3.07
Quick ratio
1.59▲
2024 · 0.13
Debt to equity
0.65▼
2024 · 1.13
ROE
45.2%▲
2024 · 30.5%
ROA
27.4%▲
2024 · 14.3%
Debt ≤ 1 year
€12k▼
2024 · €15k
Debt > 1 year
€13k▲
2024 · €9k
Income taxes
€7k▲
2024 · €2k
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2025 against 2024 · 39 lines
Balance sheet
Code20242025
Assets
Total assets20/58€46k€64k▲
Current assets29/58€46k€64k▲
Stocks and contracts in progress3€44k€45k▲
Stocks30/36€44k€45k▲
Amounts receivable within one year40/41€2k€1k▼
Trade receivables40€2k€923▼
Other amounts receivable41€0€451▲
Cash at bank and in hand54/58-€12k
Deferred charges and accrued income490/1€39€7k▲
Equity and liabilities
Total equity and liabilities10/49€46k€64k▲
Equity10/15€21k€39k▲
Contributions10/11€1k€1k=
Reserves13€20k€38k▲
Distributable reserves133€20k€38k▲
Amounts payable17/49€24k€25k▲
Amounts payable after more than one year17€9k€13k▲
Financial debts170/4€1k-
Other amounts payable178/9€8k€13k▲
Amounts payable within one year42/48€15k€12k▼
Current portion of amounts payable after more than one year42€5k€1k▼
Financial debts43€174-
Other loans439€174-
Trade debts44€3k€1k▼
Suppliers440/4€3k€1k▼
Taxes, remuneration and social security45€4k€10k▲
Taxes450/3€4k€10k▲
Other amounts payable47/48€4k-
Income statement
Code20242025
Other operating charges640/8€416€3k▲
Gross operating margin9900€10k€28k▲
Operating profit (loss)9901€10k€25k▲
Financial charges65/66B€505€326▼
Recurring financial charges65€505€326▼
Profit (loss) for the period before taxes9903€9k€25k▲
Income taxes67/77€2k€7k▲
Profit (loss) for the period9904€7k€18k▲
Profit (loss) for the period to be appropriated9905€7k€18k▲
Appropriation of the result
Profit (loss) to be appropriated9906€7k€18k▲
Transfer to equity691/2€7k€18k▲
To other reserves6921€7k€18k▲
The notes to these accounts (1 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
30-08
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema · 30 days late
2025
31-12
Financial
Highest result since 2021net €18k ▲170%
Operating result €25k, net result €18k, both a record.
09-10
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema · 70 days late
2024
10-07
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
2023
31-12
Financial
Weakest financial yearnet €3k ▼15.1%
Net result drops to €3k, the lowest in the series; recovery starts the following year.
30-05
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema
2022
18-05
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Colfontaine · 1 establishment unit since 2021
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Rue Saint-Pierre 1217340 ColfontaineGround area
1,136 m²
Building footprint
210 m²
Volume, LiDAR
1,601 m³
2 parcels, Wallonia · tallest building 12.1 m, ±3 floors. Linked by address, not a title deed.
1 establishment unit
OKINEO System
since 20212.312.979.945
2 parcels
Wallonia
2
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 53302B0013/00N002 | Wallonia | 938 m² | 1 · 129 m² | 12.1 m · 3 fl. |
| 53302B0005/00A002 | Wallonia | 198 m² | 1 · 80 m² | 5.2 m · 1 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1 · via establishment units: 1
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
Apotheek De Groot Kris
BE 0878.991.333
Westerlo · Eq €39,168
ERAPHAR
BE 0785.516.292
Haaltert · Eq €39,157
PHARMACIE LATINIS
BE 0642.672.015
Schaarbeek · Eq €39,210
TUPHARMA CONNECT AND TRADE
BE 0745.588.619
Gent · Eq €39,357
HM PHARMACEUTICALS
BE 1013.811.930
Ukkel · Eq €38,973
Of 5,220 companies in sector 47730 we hold annual accounts for 3,861. 2,401 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded13-01-2021
Fiscal year end31-12
Activities, NACEBEL 2025
47730Retail sale of pharmaceutical products
47741Retail sale of medical and orthopaedic goods, excluding prescription glasses and lenses
Sources
Crossroads Bank for EnterprisesNational Bank · 5 filingsAddress and cadastre registers
Scores and ratios are computed by Checked and are not a credit decision.